As a result of the expansion in the area of pharmaceutical medicine
there is an ever-increasing need for educational resources. id=’OLE_LINK11′ name=’OLE_LINK11’>The Dictionary of Clinical
Trials, Second Edition comprehensively explains the
3000 words and short phrases commonly used when designing, running,
analysing and reporting clinical trials.
This book is a quick, pocket reference tool to understand the
common and less well-used terms within the discipline of clinical
trials, and provides an alternative to the textbooks available.
Terms are heavily cross-referenced, which helps the reader to
understand how terms fit into the broad picture of clinical
trials.
* Wide ranging, brief, pragmatic explanations of clinical trial
terminology
* Scope includes medical, statistical, epidemiological, ethical,
regulatory and data management terminology
* Thoroughly revised and expanded – increase of 280 terms from
First Edition, reference to Cochrane included
From the reviews of the First Edition:
‘This invaluable text explains the majority of clinical trial
terms, in alphabetical order, that are likely to be found in
clinical trial protocols, reports, regulatory guidelines, and
published manuscripts… Fully comprehensive – provides definitions
of clinical trial terms in one complete volume… Includes
extensive use of graphs throughout.’ LA DOC STI
‘…covers a range of subject matter, with emphasis on
medical, statistical, epidemiological and ethical terms… a useful
adjunct to standard clinical trial texts… a reference source to
keep within easy reach.’ TALANTA
The Dictionary of Clinical Trials, Second Edition
is a ‘must-have’ for all pharmaceutical companies who
conduct a lot of clinical trials, in all or one therapeutic
area. The book is also of interest for public health and
health science workers, and for contract research organisations and
departments of medicine, where medics are involved with clinical
trials.
İçerik tablosu
Preface to the Second Edition.
Preface to the First Edition.
The Ground Rules.
Bibliography.
A to Z entries.
Appendix 1: ICH ‘Efficacy’ Guidelines.
Appendix 2: Pharmaceutical Forms (or Dosage Forms).
Appendix 3: Routes of Administration.
Yazar hakkında
Simon Day has wide experience working as a statistician in the pharmaceutical industry and heading the UK regulatory authority’s statistics unit. He has published widely on clinical trial methods as well as results from studies. He has served on many journal editorial boards and is an Associate Editor of Statistics in Medicine.
Aynı yazardan daha fazla e-kitap / Editör
144.005 Bu kategorideki e-kitaplar
